![Greg S. Klein](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Oorsprong van het eerstegraads netwerk van Greg S. Klein
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Inland Truck Parts Co.
![]() Inland Truck Parts Co. Trucks/Construction/Farm MachineryProducer Manufacturing Inland Truck Parts Co. sells parts for trucks and trailers. It offers air conditioning parts and brake systems, cables and hoses, cases, clutches, differentials, drivelines, electrical parts, engines, power take off - hydraulics parts, pro-guardian parts, springs-suspension-steering parts, transfer cases and transmissions. The firm offers air conditioning, alignments, brake, wheel-end, clutches, electrical, steering, transfer cases and preventative maintanance services. The company was founded in 1944 and is headquartered in Overland Park, KS.
3
| Private Company | Trucks/Construction/Farm Machinery | 3 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Greg S. Klein via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
Revelar Biotherapeutics, Inc.
![]() Revelar Biotherapeutics, Inc. BiotechnologyHealth Technology Revelar Biotherapeutics is a biopharmaceutical company based in Bethesda, MD. Revelar Biotherapeutics, Inc. focuses on developing and commercializing breakthrough therapeutic antibody products to address critical unmet patient needs, particularly in the field of COVID-19 and other therapeutic areas. The company's management team has extensive expertise in clinical development, regulatory affairs, business development, and operations with leading pharmaceutical companies. Revelar was spun out of Twist Bioscience in November 2021 and has the ability to leverage Twist Biopharma's antibody discovery and optimization platform to license additional antibodies for non-COVID targets. The company's therapeutic areas of interest include oncology and infectious diseases. Revelar aims to combine its clinical development and commercialization capabilities with Twist's innovative technology platform and industry and academia collaborations to accelerate the discovery and delivery of transformative antibody therapeutics to meet patients' unmet needs. Revelar was founded by Kevin P. Malobisky, and the CEO is Glenn Marina. | Biotechnology | Director/Board Member |
Statistieken
Internationaal
Verenigde Staten | 2 |
Sectoraal
Health Technology | 2 |
Operationeel
Director/Board Member | 4 |
Chief Executive Officer | 1 |
Sterkste connecties
Insiders | |
---|---|
David Scheer | 2 |
Lawrence Scheer | 1 |
Bret Wilson | 1 |
- Beurs
- Insiders
- Greg S. Klein
- Bedrijfsconnecties